181 related articles for article (PubMed ID: 24423449)
1. Suppression of GNAI2 message in ovarian cancer.
Raymond JR; Appleton KM; Pierce JY; Peterson YK
J Ovarian Res; 2014 Jan; 7():6. PubMed ID: 24423449
[TBL] [Abstract][Full Text] [Related]
2.
Ha JH; Jayaraman M; Yan M; Dhanasekaran P; Isidoro C; Song YS; Dhanasekaran DN
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439877
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G
Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362
[TBL] [Abstract][Full Text] [Related]
4. Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma.
Jiang L; Dai Y; Liu X; Wang C; Wang A; Chen Z; Heidbreder CE; Kolokythas A; Zhou X
Hum Genet; 2011 Feb; 129(2):189-97. PubMed ID: 21079996
[TBL] [Abstract][Full Text] [Related]
5. GNAI2 Is a Risk Factor for Gastric Cancer: Study of Tumor Microenvironment (TME) and Establishment of Immune Risk Score (IRS).
Yu H; Liu S; Wu Z; Gao F
Oxid Med Cell Longev; 2022; 2022():1254367. PubMed ID: 36275898
[TBL] [Abstract][Full Text] [Related]
6. Guanine nucleotide-binding protein G(i)α2 aggravates hepatic ischemia-reperfusion injury in mice by regulating MLK3 signaling.
Sun Q; He Q; Xu J; Liu Q; Lu Y; Zhang Z; Xu X; Sun B
FASEB J; 2019 Jun; 33(6):7049-7060. PubMed ID: 30840837
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis based gene expression profiling reveals functional genes in ovarian cancer.
Zhao L; Li Y; Zhang Z; Zou J; Li J; Wei R; Guo Q; Zhu X; Chu C; Fu X; Yue J; Li X
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33135729
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy.
Specht K; Harbeck N; Smida J; Annecke K; Reich U; Naehrig J; Langer R; Mages J; Busch R; Kruse E; Klein-Hitpass L; Schmitt M; Kiechle M; Hoefler H
Breast Cancer Res Treat; 2009 Nov; 118(1):45-56. PubMed ID: 18925433
[TBL] [Abstract][Full Text] [Related]
9. Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancer.
Wilcox CB; Feddes GO; Willett-Brozick JE; Hsu LC; DeLoia JA; Baysal BE
BMC Cancer; 2007 Dec; 7():223. PubMed ID: 18070364
[TBL] [Abstract][Full Text] [Related]
10. Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.
Lawrenson K; Sproul D; Grun B; Notaridou M; Benjamin E; Jacobs IJ; Dafou D; Sims AH; Gayther SA
Carcinogenesis; 2011 Oct; 32(10):1540-9. PubMed ID: 21859834
[TBL] [Abstract][Full Text] [Related]
11. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
Ho SM; Lau KM; Mok SC; Syed V
Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer.
Tung CH; Kuo LW; Huang MF; Wu YY; Tsai YT; Wu JE; Hsu KF; Chen YL; Hong TM
Oncogene; 2020 Jan; 39(4):862-876. PubMed ID: 31570789
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.
Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J
Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043
[TBL] [Abstract][Full Text] [Related]
14. Highly and moderately aggressive mouse ovarian cancer cell lines exhibit differential gene expression.
Du F; Li Y; Zhang W; Kale SP; McFerrin H; Davenport I; Wang G; Skripnikova E; Li XL; Bowen NJ; McDaniels LB; Meng YX; Polk P; Liu YY; Zhang QJ
Tumour Biol; 2016 Aug; 37(8):11147-11162. PubMed ID: 26935058
[TBL] [Abstract][Full Text] [Related]
15. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.
Mok SC; Chao J; Skates S; Wong K; Yiu GK; Muto MG; Berkowitz RS; Cramer DW
J Natl Cancer Inst; 2001 Oct; 93(19):1458-64. PubMed ID: 11584061
[TBL] [Abstract][Full Text] [Related]
16. GNAI2 Promotes Proliferation and Decreases Apoptosis in Rabbit Melanocytes.
Hu S; Dai Y; Bai S; Zhao B; Wu X; Chen Y
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440304
[TBL] [Abstract][Full Text] [Related]
17. Impaired trafficking of Gnai2+/- and Gnai2-/- T lymphocytes: implications for T cell movement within lymph nodes.
Hwang IY; Park C; Kehrl JH
J Immunol; 2007 Jul; 179(1):439-48. PubMed ID: 17579064
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
Fang L; Wang H; Li P
Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance and biological function of lncRNA SOCAR in serous ovarian carcinoma.
Guo Q; Wang L; Zhu L; Lu X; Song Y; Sun J; Wu Z; Shi J; Wang Z; Zhou X
Gene; 2019 Sep; 713():143969. PubMed ID: 31299360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
